[{"data": {"name": "Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ole-Petter R. Hamnvik", "@type": "Person"}, {"name": "Toni K. Choueiri", "@type": "Person"}, {"name": "Alexander Turchin", "@type": "Person"}, {"name": "Rana R. McKay", "@type": "Person"}, {"name": "Lipika Goyal", "@type": "Person"}, {"name": "Michael Davis", "@type": "Person"}, {"name": "Marina D. Kaymakcalan", "@type": "Person"}, {"name": "Jonathan S. Williams", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4293233?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1002/cncr.28972", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCXW7DZaR5zDK-CTWwjZ4jv9pje-CD2UqsVMuepCB-CRE3VmoPiZN5e", "propertyID": "ISCC"}], "datePublished": "2014-09-18"}, "schema": "schema.org", "mediatype": "application/ld+json"}]